These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7503758)

  • 1. 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.
    Smith PB; Tiano HF; Nesnow S; Boyd MR; Philpot RM; Langenbach R
    Biochem Pharmacol; 1995 Nov; 50(10):1567-75. PubMed ID: 7503758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
    Rainov NG; Dobberstein KU; Sena-Esteves M; Herrlinger U; Kramm CM; Philpot RM; Hilton J; Chiocca EA; Breakefield XO
    Hum Gene Ther; 1998 Jun; 9(9):1261-73. PubMed ID: 9650611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.
    Mohr L; Rainov NG; Mohr UG; Wands JR
    Cancer Gene Ther; 2000 Jul; 7(7):1008-14. PubMed ID: 10917203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Tiano HF; Hosokawa M; Chulada PC; Smith PB; Wang RL; Gonzalez FJ; Crespi CL; Langenbach R
    Carcinogenesis; 1993 Jul; 14(7):1421-7. PubMed ID: 8330360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/2CL8 cells expressing human cytochrome P450 2A6.
    Nesnow S; Beck S; Rosenblum S; Lasley J; Tiano HF; Hosokawa M; Crespi CL; Langenbach R
    Mutat Res; 1994 Jul; 324(3):93-102. PubMed ID: 8022436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter.
    Hsu H; Rainov NG; Quinones A; Eling DJ; Sakamoto KM; Spear MA
    Anticancer Res; 2003; 23(3B):2723-8. PubMed ID: 12894565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP4B1 activates 4-ipomeanol in rat lung.
    Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma.
    Rainov NG; Sena-Esteves M; Fraefel C; Dobberstein KU; Chiocca EA; Breakefield XO
    Adv Exp Med Biol; 1998; 451():393-403. PubMed ID: 10026902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy.
    Steffens S; Frank S; Fischer U; Heuser C; Meyer KL; Dobberstein KU; Rainov NG; Kramm CM
    Cancer Gene Ther; 2000 May; 7(5):806-12. PubMed ID: 10830728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug-activating Gene Therapy with Rabbit Cytochrome P450 4B1/4-Ipomeanol or 2-Aminoanthracene System in Glioma Cells.
    Jang SJ; Kang JH; Lee TS; Kim SJ; Kim KI; Lee YJ; Cheon GJ; Choi CW; Lim SM
    Nucl Med Mol Imaging; 2010 Sep; 44(3):193-8. PubMed ID: 24899949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-Activity Relationships for CYP4B1 Bioactivation of 4-Ipomeanol Congeners: Direct Correlation between Cytotoxicity and Trapped Reactive Intermediates.
    Kowalski JP; McDonald MG; Whittington D; Guttman M; Scian M; Girhard M; Hanenberg H; Wiek C; Rettie AE
    Chem Res Toxicol; 2019 Dec; 32(12):2488-2498. PubMed ID: 31799839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: cloning and characterization of mouse CYP4B1.
    Imaoka S; Hiroi T; Tamura Y; Yamazaki H; Shimada T; Komori M; Degawa M; Funae Y
    Arch Biochem Biophys; 1995 Aug; 321(1):255-62. PubMed ID: 7639529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual regulation of cytochrome P450EF expression via the aryl hydrocarbon receptor and protein stabilization in C3H/10T1/2 cells.
    Savas U; Jefcoate CR
    Mol Pharmacol; 1994 Jun; 45(6):1153-9. PubMed ID: 8022408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of a rat cytochrome P450b cDNA into C3H10T1/2CL8 mouse embryo fibroblasts.
    Hansen SK; Ross JA; Siegfried JM; Leavitt S; Rudo K; Langenbach R; Nesnow S
    Mol Carcinog; 1989; 2(5):261-7. PubMed ID: 2604864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
    Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
    Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate.
    Baer BR; Rettie AE; Henne KR
    Chem Res Toxicol; 2005 May; 18(5):855-64. PubMed ID: 15892579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol.
    Parkinson OT; Liggitt HD; Rettie AE; Kelly EJ
    Toxicol Sci; 2013 Aug; 134(2):243-50. PubMed ID: 23748241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
    Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM
    Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning, sequencing, and functional studies of phenobarbital-inducible forms of cytochrome P450 2B and 4B expressed in rabbit kidney.
    Ryan R; Grimm SW; Kedzie KM; Halpert JR; Philpot RM
    Arch Biochem Biophys; 1993 Aug; 304(2):454-63. PubMed ID: 8346920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.